Literature DB >> 16158458

Radiation therapy for localized low-grade non-Hodgkin's lymphomas.

Richard W Tsang1, Mary K Gospodarowicz.   

Abstract

The most common low grade B-cell non-Hodgkin's lymphomas are follicular lymphomas, and extranodal marginal zone lymphomas, also known as mucosa-associated lymphoid tissue (MALT) lymphomas. Localized presentations of follicular lymphoma occur in 20-30% of cases, while for MALT lymphomas, stage I-II disease presentations occur in 70-90%. These are radiation-sensitive lymphomas. Following moderate dose local radiation treatment (30-35 Gy) for these stage I and II low grade lymphomas, the clinical results indicate long-term local control and possible cure. While local control is achieved with minimal morbidity with involved-field radiation therapy, a significant proportion of patients relapse with systemic disease outside of radiation fields. For follicular lymphoma, this occurs in approximately 50% of patients after 15 years, and for non-gastric MALT lymphoma, 30-40% after 10 years. Although patients with relapsed systemic disease are not curable with chemotherapy, the disease often behaves in an indolent fashion and prolonged survival is observed. For gastric MALT lymphomas, radiation therapy is indicated in patients whose lymphoma did not respond to Helicobacter pylori eradication therapy, or in gastric lymphoma not related to this microorganism. The subject of causative agents responsible for non-gastric MALT lymphomas is under active study and the identification of putative microorganisms will lead to improved treatment strategies for these unusual lymphomas, similar to the success in gastric lymphomas over the last decade. Copyright 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2005        PMID: 16158458     DOI: 10.1002/hon.743

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN: 0278-0232            Impact factor:   5.271


  12 in total

1.  Outcome of patients with early-stage follicular lymphoma staged with 18F-Fluorodeoxyglucose (FDG) positron emission tomography (PET) and treated with radiotherapy alone.

Authors:  Sweet Ping Ng; Richard Khor; Mathias Bressel; Michael MacManus; John F Seymour; Rodney J Hicks; Andrew Wirth
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-08-07       Impact factor: 9.236

2.  4D-Listmode-PET-CT and 4D-CT for optimizing PTV margins in gastric lymphoma : Determination of intra- and interfractional gastric motion.

Authors:  Gabriele Reinartz; Uwe Haverkamp; Ramona Wullenkord; Philipp Lehrich; Jan Kriz; Florian Büther; Klaus Schäfers; Michael Schäfers; Hans Theodor Eich
Journal:  Strahlenther Onkol       Date:  2016-02-22       Impact factor: 3.621

Review 3.  Marginal Zone Lymphoma: Clinicopathologic Variations and Approaches to Therapy.

Authors:  Sabarish Ayyappan; Basem M William
Journal:  Curr Oncol Rep       Date:  2018-03-23       Impact factor: 5.075

4.  A phase 2 trial of deep-inspiration breath hold in radiotherapy of gastric lymphomas.

Authors:  Peter Meidahl Petersen; Laura Ann Rechner; Lena Specht
Journal:  Phys Imaging Radiat Oncol       Date:  2022-05-16

5.  Marginal zone lymphoma: old, new, targeted, and epigenetic therapies.

Authors:  Monika Joshi; Hassan Sheikh; Kamal Abbi; Sarah Long; Kamal Sharma; Mark Tulchinsky; Elliot Epner
Journal:  Ther Adv Hematol       Date:  2012-10

6.  Comparison of CT, PET, and PET/CT for staging of patients with indolent non-Hodgkin's lymphoma.

Authors:  Barbara J Fueger; Kristen Yeom; Johannes Czernin; James W Sayre; Michael E Phelps; Martin S Allen-Auerbach
Journal:  Mol Imaging Biol       Date:  2009-03-27       Impact factor: 3.488

7.  Follicular lymphoma in the United States: first report of the national LymphoCare study.

Authors:  Jonathan W Friedberg; Michael D Taylor; James R Cerhan; Christopher R Flowers; Hildy Dillon; Charles M Farber; Eric S Rogers; John D Hainsworth; Elaine K Wong; Julie M Vose; Andrew D Zelenetz; Brian K Link
Journal:  J Clin Oncol       Date:  2009-02-09       Impact factor: 44.544

Review 8.  Therapy of gastric mucosa associated lymphoid tissue lymphoma.

Authors:  Andrea Morgner; Renate Schmelz; Christian Thiede; Manfred Stolte; Stephan Miehlke
Journal:  World J Gastroenterol       Date:  2007-07-14       Impact factor: 5.742

9.  Response to low-dose involved-field radiotherapy in patients with non-Hodgkin's lymphoma.

Authors:  S K Luthy; A K Ng; B Silver; K O Degnan; D C Fisher; A S Freedman; P M Mauch
Journal:  Ann Oncol       Date:  2008-07-22       Impact factor: 32.976

10.  Early stage W.H.O. grade I and II follicular lymphoma treated with radiation therapy alone.

Authors:  Naseer Ahmed; Timothy E Owen; Morel Rubinger; Gaynor Williams; Zoann Nugent; Shahida Ahmed; Andrew Cooke
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.